CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Screening for Atrial Fibrillation With ECG: USPSTF Recommendation

Original Research

JOURNAL:Eur Heart J. Article Link

Systemic microvascular dysfunction in microvascular and vasospastic angina

Ford TJ, Rocchiccioli P, Good R et al. Keywords: coronary microvascular dysfunction; vasospasm; ischaemia with no obstructive coronary artery disease; peripheral small artery; microvascular angina; vasospastic angina; endothelin-1; endothelial dysfunction; vasoconstriction

FULL TEXT PDF